(Q44697151)

English

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis

scientific article published in April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

5 December 2017

0 references

steatohepatitis

0 references

14

1 reference

Europe PubMed Central

5 December 2017

Lars P. Bechmann

object named as

Lars P Bechmann

1

0 references

author name string

Peri Kocabayoglu

2

1 reference

Europe PubMed Central

5 December 2017

Jan-Peter Sowa

3

1 reference

Europe PubMed Central

5 December 2017

Svenja Sydor

4

1 reference

Europe PubMed Central

5 December 2017

Jan Best

5

1 reference

Europe PubMed Central

5 December 2017

Martin Schlattjan

6

1 reference

Europe PubMed Central

5 December 2017

Anja Beilfuss

7

1 reference

Europe PubMed Central

5 December 2017

Johannes Schmitt

8

1 reference

Europe PubMed Central

5 December 2017

Rebekka A Hannivoort

9

1 reference

Europe PubMed Central

5 December 2017

Alpaslan Kilicarslan

10

1 reference

Europe PubMed Central

5 December 2017

Christian Rust

11

1 reference

Europe PubMed Central

5 December 2017

Frieder Berr

12

1 reference

Europe PubMed Central

5 December 2017

Oliver Tschopp

13

1 reference

Europe PubMed Central

5 December 2017

Scott L Friedman

15

1 reference

Europe PubMed Central

5 December 2017

Andreas Geier

16

1 reference

Europe PubMed Central

5 December 2017

Ali Canbay

17

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 April 2013

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

57

1 reference

Europe PubMed Central

5 December 2017

4

1 reference

Europe PubMed Central

5 December 2017

1394-1406

1 reference

Europe PubMed Central

5 December 2017

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Novel insights into the pathophysiology of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acid levels are increased in the liver of patients with steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatic injury induced by bile salts: correlation between biochemical and morphological events

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile salts and cholestasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile salt transporters: molecular characterization, function, and regulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The interaction of hepatic lipid and glucose metabolism in liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Pathogenesis of non-alcoholic steatohepatitis: human data

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Enterohepatic bile salt transporters in normal physiology and liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Mitochondrial membrane perturbations in cholestasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Adiponectin and its receptors in non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Impaired liver regeneration of steatotic rats after portal vein ligation: a particular emphasis on (99m)Tc-DISIDA scintigraphy and adiponectin signaling.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

A Prospective Morphologic Evaluation of Hepatic Toxicity of Chenodeoxycholic Acid in Patients with Cholelithiasis: The National Cooperative Gallstone Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

21 January 2018

Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26225

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26225

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44697151&oldid=2032833479"